Published in PLoS One on August 18, 2010
Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A (2011) 2.09
Stem cell therapy in spinal trauma: Does it have scientific validity? Indian J Orthop (2015) 2.08
Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med (2012) 1.82
Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24
Achieving Informed Consent for Cellular Therapies: A Preclinical Translational Research Perspective on Regulations versus a Dose of Reality. J Law Med Ethics (2016) 1.22
Cell transplantation for spinal cord injury: a systematic review. Biomed Res Int (2013) 1.11
Stretch-activated ion channel Piezo1 directs lineage choice in human neural stem cells. Proc Natl Acad Sci U S A (2014) 1.11
Guided migration of neural stem cells derived from human embryonic stem cells by an electric field. Stem Cells (2012) 1.11
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury. Mol Brain (2013) 1.05
Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages. J Neurosci (2011) 1.04
Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells. Neurosurg Rev (2012) 1.04
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med (2011) 1.03
Long-term safety issues of iPSC-based cell therapy in a spinal cord injury model: oncogenic transformation with epithelial-mesenchymal transition. Stem Cell Reports (2015) 1.02
Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01
Injury to the spinal cord niche alters the engraftment dynamics of human neural stem cells. Stem Cell Reports (2014) 0.98
Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cells Transl Med (2013) 0.97
Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol (2013) 0.96
Moving stem cells to the clinic: potential and limitations for brain repair. Neuron (2015) 0.94
Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model. Exp Neurol (2013) 0.93
Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury. Stem Cell Reports (2017) 0.91
Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy. Stem Cells Transl Med (2013) 0.90
Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury. Stem Cells Transl Med (2013) 0.90
Grafted human embryonic progenitors expressing neurogenin-2 stimulate axonal sprouting and improve motor recovery after severe spinal cord injury. PLoS One (2010) 0.88
Clinical translation of human neural stem cells. Stem Cell Res Ther (2013) 0.87
Transplantation dose alters the dynamics of human neural stem cell engraftment, proliferation and migration after spinal cord injury. Stem Cell Res (2015) 0.87
Concise review: the potential of stromal cell-derived factor 1 and its receptors to promote stem cell functions in spinal cord repair. Stem Cells Transl Med (2012) 0.86
Transplantation of neural stem cells clonally derived from embryonic stem cells promotes recovery after murine spinal cord injury. Stem Cells Dev (2015) 0.85
Stem cells: A time to heal. Nature (2013) 0.84
Functional Recovery from Neural Stem/Progenitor Cell Transplantation Combined with Treadmill Training in Mice with Chronic Spinal Cord Injury. Sci Rep (2016) 0.83
Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions. Stem Cells Int (2015) 0.83
Characterization of ectopic colonies that form in widespread areas of the nervous system with neural stem cell transplants into the site of a severe spinal cord injury. J Neurosci (2014) 0.82
Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice. J Neurotrauma (2011) 0.80
Molecular imaging in stem cell therapy for spinal cord injury. Biomed Res Int (2014) 0.79
Stem cell sources for regenerative medicine: the immunological point of view. Semin Immunopathol (2011) 0.79
Translational spinal cord injury research: preclinical guidelines and challenges. Handb Clin Neurol (2012) 0.78
Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective. Neurol Sci (2012) 0.78
Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1. Dialogues Clin Neurosci (2011) 0.78
Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media. Mol Brain (2016) 0.77
Current stem cell treatments for spinal cord injury. Indian J Orthop (2012) 0.77
Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging. Stem Cells Int (2016) 0.76
Effects of atelocollagen on neural stem cell function and its migrating capacity into brain in psychiatric disease model. J Neural Transm (Vienna) (2013) 0.76
Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury. Stem Cell Reports (2016) 0.76
Neutrophils Induce Astroglial Differentiation and Migration of Human Neural Stem Cells via C1q and C3a Synthesis. J Immunol (2017) 0.76
Therapeutic potential of human olfactory bulb neural stem cells for spinal cord injury in rats. Spinal Cord (2016) 0.75
Neuronal differentiation and extensive migration of human neural precursor cells following co-culture with rat auditory brainstem slices. PLoS One (2013) 0.75
Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases. Mol Brain (2016) 0.75
Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury. Neural Plast (2015) 0.75
Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen Med (2014) 0.75
Increased Brain Sensorimotor Network Activation after Incomplete Spinal Cord Injury. J Neurotrauma (2016) 0.75
Lentivirus-mediated microRNA-124 gene-modified bone marrow mesenchymal stem cell transplantation promotes the repair of spinal cord injury in rats. Exp Mol Med (2017) 0.75
Human neural progenitors derived from integration-free iPSCs for SCI therapy. Stem Cell Res (2017) 0.75
Progress and prospects in neurorehabilitation: clinical applications of stem cells and brain-computer interface for spinal cord lesions. Neurol Sci (2012) 0.75
Current progress in the derivation and therapeutic application of neural stem cells. Cell Death Dis (2017) 0.75
Neural stem cell mediated recovery is enhanced by Chondroitinase ABC pretreatment in chronic cervical spinal cord injury. PLoS One (2017) 0.75
Systemic neutrophil depletion modulates the migration and fate of transplanted human neural stem cells to rescue functional repair. J Neurosci (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
Regeneration beyond the glial scar. Nat Rev Neurosci (2004) 11.00
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol (2009) 6.39
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci (2005) 5.66
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
The glial scar and central nervous system repair. Brain Res Bull (1999) 4.80
The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci (2003) 4.14
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A (2002) 4.03
Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci (2005) 3.74
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol (2003) 3.09
The cellular inflammatory response in human spinal cords after injury. Brain (2006) 3.01
Regeneration of adult axons in white matter tracts of the central nervous system. Nature (1998) 2.94
Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J Neurosci (1999) 2.43
Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J Neurotrauma (2001) 2.39
The pathology of human spinal cord injury: defining the problems. J Neurotrauma (2004) 2.17
Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci (2006) 2.13
Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol (2001) 2.12
Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med (2007) 2.07
Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain (2002) 2.04
SCID mouse models of human stem cell engraftment. Stem Cells (1998) 1.98
A review of the neuropathology of human spinal cord injury with emphasis on special features. J Spinal Cord Med (1999) 1.86
Overcoming inhibition in the damaged spinal cord. J Neurotrauma (2006) 1.84
Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci (1999) 1.82
NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes (1992) 1.69
Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma (2005) 1.60
Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Exp Neurol (2005) 1.59
Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins. J Neurosci (2001) 1.56
Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol (2002) 1.53
Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J Neurosci (2005) 1.47
Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration. Exp Neurol (2004) 1.36
Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur J Neurosci (2003) 1.34
Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci (2003) 1.31
Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia (2007) 1.29
Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One (2009) 1.27
Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol (2006) 1.27
Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma (2007) 1.24
Repair of chronic spinal cord injury. Exp Neurol (2003) 1.22
Homologous transplantation of neural stem cells to the injured spinal cord of mice. Neurosurgery (2005) 1.22
Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J Neurotrauma (2007) 1.21
Lithium enhances proliferation and neuronal differentiation of neural progenitor cells in vitro and after transplantation into the adult rat spinal cord. Exp Neurol (2007) 1.20
Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience (1997) 1.20
Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci (2004) 1.20
Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. Eur J Neurosci (2007) 1.20
Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury. Exp Neurol (2006) 1.18
Transplantation of oligodendrocyte precursors and sonic hedgehog results in improved function and white matter sparing in the spinal cords of adult rats after contusion. Spine J (2004) 1.17
No evidence for chronic demyelination in spared axons after spinal cord injury in a mouse. J Neurosci (2008) 1.15
Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol (2003) 1.14
Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord. Cell Transplant (2005) 1.14
Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J Neurosci Res (2007) 1.14
Transplanted neural stem cells promote axonal regeneration through chronically denervated peripheral nerves. Exp Neurol (2004) 1.13
Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma (2003) 1.11
Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol (2006) 1.09
Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J Neurosci Res (2006) 1.08
Grafts of BDNF-producing fibroblasts rescue axotomized rubrospinal neurons and prevent their atrophy. Exp Neurol (2002) 1.08
Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord. Brain Res (2000) 1.08
Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma. Eur J Neurosci (2004) 1.04
Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury. Brain Res Bull (1989) 1.03
Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J Neurosci (2008) 1.01
Spinal implantation of hNT neurons and neuronal precursors: graft survival and functional effects in rats with ischemic spastic paraplegia. Eur J Neurosci (2004) 1.01
Emv30null NOD-scid mice. An improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes (1995) 1.01
Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol Res (2006) 1.00
Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant (2008) 0.99
Cellular composition of long-term human spinal cord- and forebrain-derived neurosphere cultures. J Neurosci Res (2006) 0.96
Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors. Gene Ther (2002) 0.96
Sensory afferents regenerated into dorsal columns after spinal cord injury remain in a chronic pathophysiological state. Exp Neurol (2007) 0.94
Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells. Neurosurgery (2005) 0.94
Evaluation of human fetal neural stem/progenitor cells as a source for cell replacement therapy for neurological disorders: properties and tumorigenicity after long-term in vitro maintenance. J Neurosci Res (2009) 0.88
Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine. Exp Neurol (1997) 0.87
Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury. J Neurotrauma (2010) 0.84
Regeneration-based therapies for spinal cord injuries. Neurochem Int (2007) 0.80
Partial recovery after treatment of chronic paraplegia in rat. Exp Neurol (2004) 0.80
Olfactory glia and CNS repair: a step in the road from proof of principle to clinical application. Brain (2000) 0.77
Functional recovery in chronic paraplegic rats after co-grafts of fetal brain and adult peripheral nerve tissue. Surg Neurol (2001) 0.77
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma (2006) 5.32
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol (2005) 2.22
Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J Neurotrauma (2006) 2.14
Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res (2002) 2.07
Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A (2007) 2.03
Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3. Development (2004) 1.86
Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med (2012) 1.82
Assessing behavioural function following a pyramidotomy lesion of the corticospinal tract in adult mice. Exp Neurol (2005) 1.65
Voluntary wheel running improves recovery from a moderate spinal cord injury. J Neurotrauma (2005) 1.60
The assessment of locomotor function in spinal cord injured rats: the importance of objective analysis of coordination. J Neurotrauma (2005) 1.52
Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One (2009) 1.27
Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib. J Neurosci Methods (2008) 1.26
Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell (2009) 1.25
Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha. J Neurochem (2007) 1.25
Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma (2007) 1.24
Wheel running following spinal cord injury improves locomotor recovery and stimulates serotonergic fiber growth. Eur J Neurosci (2007) 1.20
Sciatic nerve regeneration in mice and rats: recovery of sensory innervation is followed by a slowly retreating neuropathic pain-like syndrome. Brain Res (2004) 1.16
Suppression of fibrous scarring in spinal cord injury of rat promotes long-distance regeneration of corticospinal tract axons, rescue of primary motoneurons in somatosensory cortex and significant functional recovery. Eur J Neurosci (2005) 1.15
Strain and locomotor speed affect over-ground locomotion in intact rats. Physiol Behav (2007) 1.14
Multifunctional, multichannel bridges that deliver neurotrophin encoding lentivirus for regeneration following spinal cord injury. Biomaterials (2011) 1.13
Complement activation in the injured central nervous system: another dual-edged sword? J Neuroinflammation (2012) 1.11
Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci U S A (2004) 1.06
Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis (2003) 1.03
Locomotor recovery after spinal cord contusion injury in rats is improved by spontaneous exercise. J Neurotrauma (2003) 1.03
Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med (2011) 1.03
Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther (2008) 1.03
Multiple channel bridges for spinal cord injury: cellular characterization of host response. Tissue Eng Part A (2009) 1.02
Deficiency in complement C1q improves histological and functional locomotor outcome after spinal cord injury. J Neurosci (2008) 1.01
Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol Res (2006) 1.00
Safety of human neural stem cell transplantation in chronic spinal cord injury. Stem Cells Transl Med (2013) 0.97
Profound differences in spontaneous long-term functional recovery after defined spinal tract lesions in the rat. J Neurotrauma (2006) 0.96
Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging. Neurobiol Aging (2002) 0.95
Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proc Natl Acad Sci U S A (2008) 0.94
Circulating insulin-like growth factor I and functional recovery from spinal cord injury under enriched housing conditions. Eur J Neurosci (2006) 0.94
Alzheimer's disease--a sum greater than its parts? Neurobiol Aging (2004) 0.93
Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury. J Neuroinflammation (2008) 0.93
An fMRI study of tool-use gestures: body part as object and pantomime. Neuroreport (2004) 0.92
The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain. Neurochem Res (2003) 0.92
Quantitative assessment of immune cells in the injured spinal cord tissue by flow cytometry: a novel use for a cell purification method. J Vis Exp (2011) 0.92
Adaptation of a ladder beam walking task to assess locomotor recovery in mice following spinal cord injury. Behav Brain Res (2007) 0.91
Activity-based therapies to promote forelimb use after a cervical spinal cord injury. J Neurotrauma (2009) 0.91
Immunosuppressants affect human neural stem cells in vitro but not in an in vivo model of spinal cord injury. Stem Cells Transl Med (2013) 0.90
Safety of epicenter versus intact parenchyma as a transplantation site for human neural stem cells for spinal cord injury therapy. Stem Cells Transl Med (2013) 0.90
Long-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatum. Stem Cells (2009) 0.90
Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small Molecules. J Huntingtons Dis (2012) 0.89
Channel density and porosity of degradable bridging scaffolds on axon growth after spinal injury. Biomaterials (2013) 0.87
Clinical translation of human neural stem cells. Stem Cell Res Ther (2013) 0.87
Non-immortalized human neural stem (NS) cells as a scalable platform for cellular assays. Neurochem Int (2011) 0.85
Exercise-induced gene expression changes in the rat spinal cord. Gene Expr (2005) 0.85
Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury. J Neurotrauma (2010) 0.84
Neuronal Ca2+ disregulation in diabetes mellitus. Eur J Pharmacol (2002) 0.84
Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen Med (2013) 0.81
Family systems theory, attachment theory, and culture. Fam Process (2002) 0.81
Long-term characterization of axon regeneration and matrix changes using multiple channel bridges for spinal cord regeneration. Tissue Eng Part A (2013) 0.81
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells. Tissue Eng Part A (2008) 0.80
Systemic co-treatment with alpha-melanocyte stimulating hormone delays hearing loss caused by local cisplatin administration in guinea pigs. Hear Res (2003) 0.78
Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin. Hear Res (2004) 0.77
BDNF-induced facilitation of afferent-evoked responses in lamina II neurons is reduced after neonatal spinal cord contusion injury. J Neurophysiol (2005) 0.77
The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat. Eur J Pharmacol (2003) 0.77
Partial recovery of cisplatin-induced hearing loss in the albino guinea pig in relation to cisplatin dose. Hear Res (2002) 0.76
Induction of early neural precursors and derivation of tripotent neural stem cells from human pluripotent stem cells under xeno-free conditions. J Comp Neurol (2014) 0.76
Functional recovery, serotonergic sprouting, and endogenous progenitor fates in response to delayed environmental enrichment after spinal cord injury. J Neurotrauma (2011) 0.76
Method for purification of human hematopoietic stem cells by flow cytometry. Methods Mol Med (2002) 0.75
Comparative non-radioactive RT-PCR assay: an approach to study the neurosteroids biosynthetic pathway in humans. J Neurosci Methods (2005) 0.75
[The development of children's thinking strategies: the retrieval of alternatives based on the categorization with conditional reasoning tasks]. Shinrigaku Kenkyu (2002) 0.75
Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity. Hear Res (2002) 0.75